The US FDA has cleared Elekta’s Comprehensive Motion Management (CMM) with True…
Recent increases in Medicare spending on outpatient cancer care at the end of…
A new analysis by Yale researchers published in the Journal of the National Cancer Institute…
Bladder cancer patients’ chance of staying cancer-free increases if they receive…
The February issue of The Journal of Nuclear Medicine (JNM) includes a new procedure…
A pivotal Phase III study for Telix Pharmaceuticals Limited’s TLX250-CDx demonstrated…
Blue Earth Diagnostics today announced additional results from its Phase 3 LIGHTHOUSE trial…
Carevive Systems, Inc. has launched its computerized cancer symptom management pathways…
Researchers at the Centre for Protein Diagnostics PRODI at Ruhr University Bochum, Germany,…
Data from the randomized, multicenter trial PACE-A (PACE - Prostate Advances in Comparative…
